首页 > 市场调查报告书 > 製药

呼吸器

市场调查报告书

商品编码

1392054

胸膜疾病市场：依疾病类型、依诊断工具、依治疗手段、依最终使用者、按地区

Pleural Diseases Market, By Disease Type, By Diagnostic Tools, By Treatment Modalities, By End User, By Geography

出版日期: 2023年11月02日 | 出版商:

Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2023年，全球胸膜疾病市场规模为50.1亿美元，预计2023年至2030年复合年增长率为7.2%，到2030年将达到81.3亿美元。

报告范围		报告详情
基准年	2022年	2023年市场规模	50.1亿美元
实绩资料	2018-2021	预测期	2023-2030
预测期复合年增长率	7.20%	2030年市场规模预测	81.3亿美元

图 1. 2023 年按地区分類的胸膜疾病全球市场占有率(%)

胸膜疾病包括影响胸膜（肺部周围的薄膜）的多种疾病。这些疾病会对呼吸功能和整体健康产生重大影响。胸膜透过提供润滑并允许呼吸过程中的平稳运动，在维持肺部结构和功能完整性方面发挥重要作用。胸膜疾病可由多种原因引起，包括感染疾病、发炎、肿瘤和接触有害物质。常见的胸膜疾病包括胸膜炎、胸腔积水、气胸和间皮瘤。识别症状、准确诊断症状并实施适当的治疗策略对于管理患者和改善全球受这些具有挑战性的胸膜疾病影响的患者的治疗结果至关重要。在吸烟、结核和转移等相关风险因子盛行率上升的推动下，全球胸膜疾病市场多年来一直稳定成长。此外，诊断影像技术和雷射治疗等诊断和治疗方法的重大技术进步正在进一步支持市场成长。

市场动态：

预计越来越多地采用协议等无机策略也将推动预测期内的市场成长。例如，2020年11月，製药公司工业 Co., Ltd.与临床阶段生物製药公司Lung Therapeutics, Inc.宣布，Lung Tx目前正在开发重组人单链尿激酶Plus我们宣布了Minogen激活剂的独家许可协议LTI-01在日本用于治疗局部胸腔积水。

然而，认知度低、诊断延迟、诊断工具和治疗成本、专业知识和资源缺乏预计将阻碍预测期内全球胸膜疾病市场的成长。

本研究的主要特点

该报告详细分析了全球胸膜疾病市场，并提供了以2022年为基准年的预测期（2023-2030）的市场规模和年复合成长率（CAGR%）。
它还揭示了各个细分市场的潜在商机，并为该市场说明了一系列有吸引力的投资提案。
它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的主要考察。
它根据公司亮点、产品系列、主要亮点、绩效和策略等参数，介绍了全球胸膜疾病市场的主要企业。
该报告的见解使行销人员和经营团队负责人就未来的产品发布、类型升级、市场扩张和行销策略做出资讯的决策。
全球胸膜疾病市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
透过用于分析全球胸膜疾病市场的各种策略矩阵，将促进相关人员的决策。

Report Coverage	Report Details
Base Year:	2022	Market Size in 2023:	US$ 5.01 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	7.20%	2030 Value Projection:	US$ 8.13 Bn

Pleural diseases encompass a diverse group of conditions affecting the pleura, the thin membrane surrounding the lungs. These conditions can significantly impact respiratory function and overall well-being. The pleura plays a crucial role in maintaining the integrity of the lung's structure and function by providing lubrication and allowing smooth movement during breathing. Pleural diseases can arise from various causes, including infections, inflammation, tumors, and exposure to hazardous substances. Common pleural disorders include pleurisy, pleural effusion, pneumothorax and mesothelioma. Recognizing the symptoms, diagnosing accurately, and implementing appropriate treatment strategies are essential in managing and improving outcomes for individuals affected by these challenging global pleural diseases. The global global pleural diseases market has been steadily growing over the years driven by the rising prevalence of associated risk factors such as smoking, tuberculosis, and metastases. Furthermore, the market has witnessed significant technological advancements in diagnosis and treatment modalities such as imaging techniques and laser therapy, further supporting the market growth.

Market Dynamics:

The increasing adoption of inorganic strategies such as agreement is also expected to drive the growth of the market over the forecast period. For instance, in November 2020, Taiho Pharmaceutical Co., Ltd, a pharmaceutical company, and Lung Therapeutics, Inc., a clinical-stage biopharmaceutical company, announced an exclusive license agreement of LTI-01, a recombinant human single-chain urokinase plasminogen activator, currently under development by Lung Tx for loculated pleural effusions, for the territory of Japan.

However, limited awareness and delayed diagnosis, cost of diagnostic tools and treatment, limited availability of expertise and resources are expected to hamper growth of the global pleural diseases market over the forecast period.

Key features of the study:

This report provides an in-depth analysis of the global pleural diseases market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the Global Pleural Diseases market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Bristol Myers Squibb, Merck & Co., Inc., GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Sanofi, AbbVie Inc., B. Braun SE, Becton, Dickinson and Company, Bicakcilar, Biometrix, Cook Medical, Grena, Redax, Rocket Medical, Smith Medical.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global pleural diseases market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pleural diseases market

Global Pleural Diseases Market Segmentation Detailed Segmentation:

By Disease Types:
- Pleurisy
- Pleural Effusion
- Pneumothelioma
- Mesothelioma
- Others
By Diagnostic Tools:
- Imaging Techniques
- Molecular Diagnostics
- Thoracoscopy and Pleuroscopy
By Treatment Modalities:
- Medications
- Thoracentesis and Pleurodesis
- Minimally Invasive Interventions
- Surgical Interventions
By End User:
- Hospitals and Clinics
- Diagnostic Centers
- Research and Academic Institutions
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profile:
- Bristol Myers Squibb
- Merck & Co., Inc.
- GlaxoSmithKline plc
- Boehringer Ingelheim International GmbH
- Sanofi
- AbbVie Inc.
- Braun SE
- Becton, Dickinson and Company
- Bicakcilar
- Biometrix
- Cook Medical
- Grena
- Redax
- Rocket Medical
- Smith Medical

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Pleural Diseases, By Disease Type
- Market Pleural Diseases, By Diagnostic Tools
- Market Pleural Diseases, By Treatment Modalities
- Market Pleural Diseases, By End User
- Market Pleural Diseases, By Geography/Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
Increasing Prevalence of Respiratory diseases
- Restraints
Limited Availability of Expertise and Resources
- Opportunities
Emerging Biomarkers and Precision Medicine
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Pleural Diseases Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Pleural Diseases Market, By Disease Type, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Pleurisy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Pleural Effusion
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Pneumothelioma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Mesothelioma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

6. Global Pleural Diseases Market, By Diagnostic Tools, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Imaging Techniques
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Molecular Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 20218-2030, (US$ Billion)
Thoracoscopy and Pleuroscopy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

7. Global Pleural Diseases Market, By Treatment Modalities, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Medications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Thoracentesis and Pleurodesis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Minimally Invasive Interventions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Surgical Interventions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

8. Global Pleural Diseases Market, By End User, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Diagnostic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Research and Academic Institutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

9. Global Pleural Diseases Market, By Region, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, By Country, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Country 2019 -2030
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Tools, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Modalities, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Tools, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Modalities, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Tools, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Modalities, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Tools, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Modalities, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Tools, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Modalities, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Tools, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Modalities, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Bn)

10. Competitive Landscape

Bristol Myers Squibb
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
GlaxoSmithKline plc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Boehringer Ingelheim International GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Sanofi
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
AbbVie Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Braun SE
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Becton, Dickinson and Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Bicakcilar
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Biometrix
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Cook Medical
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Grena
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Redax
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Rocket Medical
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Smith Medical
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views

11. Section

Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

FAQ

胸膜疾病市场：依疾病类型、依诊断工具、依治疗手段、依最终使用者、按地区

Pleural Diseases Market, By Disease Type, By Diagnostic Tools, By Treatment Modalities, By End User, By Geography

市场动态：

目录

第一章研究目的与假设

第二章市场展望

第三章市场动态、法规及趋势分析

第四章全球胸膜疾病市场 -冠状病毒(COVID-19) 大流行的影响

第五章全球胸膜疾病市场，依疾病类型，2018-2030

第六章全球胸膜疾病市场（依诊断工具），2018-2030 年

第七章全球胸膜疾病市场，依治疗方式，2018-2030

第 8 章全球胸膜疾病市场，按最终用户划分，2018-2030 年

第9章全球胸膜疾病市场，按地区，2018-2030

第10章竞争形势

第11章章节

Market Dynamics:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Pleural Diseases Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global Pleural Diseases Market, By Disease Type, 2018-2030, (US$ Bn)

6. Global Pleural Diseases Market, By Diagnostic Tools, 2018-2030, (US$ Bn)

7. Global Pleural Diseases Market, By Treatment Modalities, 2018-2030, (US$ Bn)

8. Global Pleural Diseases Market, By End User, 2018-2030, (US$ Bn)

9. Global Pleural Diseases Market, By Region, 2018-2030, (US$ Bn)

10. Competitive Landscape

11. Section

胸膜疾病市场：依疾病类型、依诊断工具、依治疗手段、依最终使用者、按地区

Pleural Diseases Market, By Disease Type, By Diagnostic Tools, By Treatment Modalities, By End User, By Geography

市场动态：

目录

第一章 研究目的与假设

第二章 市场展望

第三章市场动态、法规及趋势分析

第四章全球胸膜疾病市场 -冠状病毒(COVID-19) 大流行的影响

第五章全球胸膜疾病市场，依疾病类型，2018-2030

第六章 全球胸膜疾病市场（依诊断工具），2018-2030 年

第七章全球胸膜疾病市场，依治疗方式，2018-2030

第 8 章全球胸膜疾病市场，按最终用户划分，2018-2030 年

第9章全球胸膜疾病市场，按地区，2018-2030

第10章竞争形势

第11章 章节

Market Dynamics:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Pleural Diseases Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global Pleural Diseases Market, By Disease Type, 2018-2030, (US$ Bn)

6. Global Pleural Diseases Market, By Diagnostic Tools, 2018-2030, (US$ Bn)

7. Global Pleural Diseases Market, By Treatment Modalities, 2018-2030, (US$ Bn)

8. Global Pleural Diseases Market, By End User, 2018-2030, (US$ Bn)

9. Global Pleural Diseases Market, By Region, 2018-2030, (US$ Bn)

10. Competitive Landscape

11. Section

第一章研究目的与假设

第二章市场展望

第六章全球胸膜疾病市场（依诊断工具），2018-2030 年

第11章章节